Cannabis Science Supports Patients Out of Time's Eighth National Clinical Conference on Cannabis Therapeutics held May 8-10, 2014 in Portland, Oregon

The Endocannabinoid System and Age-Related Illnesses; Accredited for Continuing Medical Education

PR Newswire

COLORADO SPRINGS, Colo., May 1, 2014 /PRNewswire/ -- Cannabis Science, Inc. (CBIS), a U.S. Company specializing in cannabis based drug development and related consulting is proud to support the Eighth National Clinical Conference on Cannabis Therapeutics sponsored by the not-for-profit Patients Out of Time in conjunction with the University of California, San Francisco, School of Medicine (UCSF).  The conference, "The Endocannabinoid System and Age Related Illness," convenes in Portland, Oregon, May 8 through May 10 and is accredited to provide continuing education credits for healthcare providers. 

Patients Out of Time clinical cannabis educational series began in 2000. Through its conferences and on-going educational initiatives, the organization has become a leader in the field of medical cannabis education, helping patients and medical professionals understand why cannabis use continues to be a viable medical option for multiple conditions and diseases.

"As a company, we are committed to continuing and strengthening our support of Patients Out of Time in the years ahead.  The organization's work is truly an inspiration to all of us who aim to increase the understanding of the efficacy of medical cannabis based on science," said Dorothy H. Bray, Ph.D., Director and CEO of Cannabis Science, Inc. 

The upcoming conference will be held at the Portland University Place Hotel and Natural College of Natural Medicine beginning May 8th.  The conference has attracted top experts in the medical cannabis field of research and clinical use.  Topics will be diverse but will focus on the endocannabinoid system and the role that cannabis and/or cannabinoids may provide in age-related illnesses, since the baby boomers are reaching retirement.

Continuing education information may be found here:

Registration and conference information may be found here

The conference brochure of speakers and topics may be found here

The Facebook event page may be found here

Cannabis Science is a conference supporter for the second time after supporting the 2012 Conference held in Tucson, Arizona.  Cannabis Science executives will be presenting at and attending the conference and all related events, and the Company will have a table with Company information as a resource for speakers and attendees.

About Patients Out of Time

Patients Out of Time is "a compassionate, science-based education forum for the restoration of medical cannabis knowledge" comprised entirely of volunteers:  patients, clinicians and scientists who are involved in the medical cannabis arena.  The organization depends on individual donations and company/foundation grants for financing. Formed in 1995 by the original federal IND cannabis patients, interested healthcare providers, and, among others, Al Byrne and Mary Lynn Mathre, RN, Patients Out of Time's mission is to educate health care professionals and the public about therapeutic cannabis.  To execute the mission, the organization has developed a network of national professional organizations and other reputable groups, providing a supportive environment for individual physicians, nurses and other professionals to more openly join the medical cannabis conversation.  This movement resulted in the establishment of the clinical conferences on cannabis therapeutics.  For more information about Patients Out of Time, please visit the organization's website at

About Cannabis Science, Inc.

Cannabis Science, Inc., takes advantage of its unique understanding of metabolic processes to provide novel treatment approaches to a number of illnesses for which current treatments and understanding remain unsatisfactory. Cannabinoids have an extensive history dating back thousands of years, and currently there are a growing number of peer-reviewed scientific publications that document the underlying biochemical pathways that cannabinoids modulate. The Company works with leading experts in drug development, medicinal characterization, and clinical research to develop, produce, and commercialize novel therapeutic approaches for the treatment for illnesses caused by infections as well as for age-related illness. Our initial focus is on skin cancers and neurological conditions.

Forward Looking Statements

This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing words such as "anticipate," "seek," intend," "believe," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Science, Inc., does not undertake any duty nor does it intend to update the results of these forward-looking statements.

Cannabis Science, Inc.
Dr. Dorothy Bray, CEO & Director
Tel: 1.888.777.0658

Investment Inquiries
Robert Kane, CFO & Director

View Comments (0)